XEML news

Xtrackers Europe Market Leaders · Europe

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Seeking Alpha · 28 Oct 2026, 18:55 UTC
Roche: Valuation Leaves Limited Upside (OTCMKTS:RHHBF) | Seeking Alpha
4.7% of XEML
Bloomberg Business · 28 Oct 2026, 18:59 UTC
Deutsche Telekom Is Said to Hit Brakes on Giant T-Mobile Merger
4.5% of XEML
Quartz · 28 Oct 2026, 20:39 UTC
Consumer boycotts that worked: 9 that forced change
4.3% of XEML
Quartz · 28 Oct 2026, 17:20 UTC
Lilly's retatrutide more than doubled Ozempic weight loss in trial
4.5% of XEML
Where to buy XEML
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
4.5% of XEML
Financial Post · 28 Oct 2026, 00:00 UTC
How Brands Do Agentic Marketing Today: Lessons From the 2026 Contentstack Experience Award Winners
3.9% of XEML
Where to buy XEML
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Bloomberg Business · 28 Oct 2026, 19:00 UTC
How's the US-China Tech War Going? Ask AI
4.0% of XEML
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
4.5% of XEML
wallstreet:online · 28 Oct 2026, 14:05 UTC
Sandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidance
4.4% of XEML
Seeking Alpha · 28 Oct 2026, 15:21 UTC
SK hynix: Don't Panic Over The Immediate Threat Of CXMT's 4F Squared Efforts (NASDAQ:SKHY) | Seeking Alpha
4.0% of XEML
Seeking Alpha · 28 Oct 2026, 12:00 UTC
Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking Alpha
4.4% of XEML
wallstreet:online · 28 Oct 2026, 13:05 UTC
American Business Bank Reports Record Quarterly Earnings of $17.2 Million
4.2% of XEML
Seeking Alpha · 28 Oct 2026, 15:37 UTC
SAP replaces pricey AI models with more affordable alternatives: report | Seeking Alpha
3.9% of XEML
The Manila times · 28 Oct 2026, 11:10 UTC
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
4.4% of XEML
Market Screener · 28 Oct 2026, 14:13 UTC
SAP swaps costly AI models for cheaper alternatives, targets over EUR2 billion in gains
3.9% of XEML
Reuters · 28 Oct 2026, 14:08 UTC
SAP swaps costly AI models for cheaper alternatives, targets over €2 bln in gains
3.9% of XEML
Seeking Alpha · 28 Oct 2026, 13:55 UTC
Dodge & Cox International Stock Fund Q3 2026 Commentary | Seeking Alpha
3.9% of XEML
The Wall Street Journal · 28 Oct 2026, 09:49 UTC
Sandoz Shares Fall After Company Turns Cautious on Sales Guidance
4.4% of XEML
Investing.com · 28 Oct 2026, 09:35 UTC
Earnings call transcript: Sandoz narrows 2026 sales view after strong Q3 By Investing.com
4.4% of XEML
Bloomberg Business · 28 Oct 2026, 09:34 UTC
Sandoz Warns EU May Scrap Antibiotic Protection, Risking Plant
4.4% of XEML